Last reviewed · How we verify

NCT06232811

Mother-to-infant Bonding and Prematurity Are Associated With Sensory Processing at 12 Months of Age

Completed Last updated 31 January 2024
What this trial tests

trial testing Assessment in Preterm in 42 participants. Completed in 15 January 2024.

Timeline
21 April 2023
Primary endpoint
21 November 2023
15 January 2024

Quick facts

Lead sponsorGazi University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment42
Start date21 April 2023
Primary completion21 November 2023
Estimated completion15 January 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gazi University

Who can join

Adults 12 Months to 12 Months, any sex, with Preterm or Sensory Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Establishing a strong bond between mother and infant is crucial for fostering healthy relationships in the future. This research sought to investigate the correlation between mother-to-infant bonding and sensory processing, as well as the connection between prematurity and sensory processing in 12-month-old infants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Assessment

Trials testing the same drug.

Other recruiting trials for Preterm

Currently open trials in the same condition.

Other Gazi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06232811.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing